Locating Biobanks in the Canadian Privacy Maze.
| Autor: | Saulnier KM; Katie M. Saulnier, B.A., B.C.L./LL.B., is a researcher with the Centre of Genomics and Policy at McGill University in Montreal. Yann Joly, D.C.L., is the Research Director of the Centre of Genomics and Policy and an Associate Professor at McGill University in Montreal., Joly Y; Katie M. Saulnier, B.A., B.C.L./LL.B., is a researcher with the Centre of Genomics and Policy at McGill University in Montreal. Yann Joly, D.C.L., is the Research Director of the Centre of Genomics and Policy and an Associate Professor at McGill University in Montreal. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics [J Law Med Ethics] 2016 Mar; Vol. 44 (1), pp. 7-19. |
| DOI: | 10.1177/1073110516644185 |
| Abstrakt: | Although Canada has not yet enacted any biobanking-specific privacy law, guidance and oversight are provided via various federal and provincial health and privacy-related laws as well as via ethics and policy documents. The primary policy document governing health research, the Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans, provides the framework for the strong role of Research Ethics Boards in Canada, and limits research funding from Canada's three main federal funding agencies to those who agree to adhere to its policies. The broad consent model is gaining traction in Canada, although lack of legal and constitutional precedence for the broad consent or opt-out options makes this an evolving issue. In general, data is required to be coded; more specific security measures are outlined in guidelines that may be implemented by local policy. International sharing is allowed, and Canada meets the European Union's standards for receipt of data and samples. (© 2016 American Society of Law, Medicine & Ethics.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|